BRENZAVVY (bren-ZA-vee) can help healthcare professionals with patients who need an affordable, once-daily prescription pill that costs around $50 / month with or without insurance.
Choose BRENZAVVY (bexagliflozin) for your adult patients with type 2 diabetes.
BRENZAVVY is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Backed by an extensive program of rigorously conducted clinical experimentation, BRENZAVVY has been found to produce significant improvements in glycemic control while also offering modest decreases in body weight and systolic blood pressure. BRENZAVVY was the first SGLT2 inhibitor shown in a randomized, controlled clinical trial to be effective in adults with type 2 diabetes and stage 3 (3a + 3b) chronic kidney disease.
BRENZAVVY extends the therapeutic benefits of SGLT2 inhibition to the diabetic population with stage 3 CKD.
BRENZAVVY is available through several online pharmacies and independent pharmacies nationwide
BRENZAVVY is FDA approved as an oral tablet containing 20 mg of bexagliflozin to be taken once daily.
(BRENZAVVY (bexagliflozin) is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.)
Are you a healthcare professional?
This section contains information intended for healthcare professionals in the United States only and is not intended for the general public.